糖尿病视网膜病变筛查:新视角与挑战
本文综述了全球糖尿病视网膜病变所致视力损害和失明的患病率变化、筛查的必要性、个性化筛查间期、新技术(超广角成像、远程眼科、人工智能)对筛查策略和成本效益的影响,以及视网膜成像在识别心血管疾病或认知障碍风险中的潜在作用。
要点
- 全球糖尿病视网膜病变所致视力损害和失明的粗患病率在1990至2015年间上升,主要因2型糖尿病患病率增加所致。
- 考虑多种风险因素的个性化筛查间期已被提出,并具有良好的成本效益比。
- 新兴证据提示视网膜成像可能有助于识别心血管疾病或认知障碍风险个体,拓展筛查的潜在作用。
核心结论
- 糖尿病视网膜病变筛查对于检出需及时全面眼科检查 and 治疗的可转诊病例至关重要,以避免永久性视力丧失;新技术正在改变筛查策略并提高成本效益。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- 自1980年以来,在糖尿病控制改善的人群中,所有分期糖尿病视网膜病变的患病率一直在下降。
- 1990年至2015年间,全球由糖尿病视网膜病变引起的视力损害和失明的粗患病率增加,很大程度上归因于2型糖尿病患病率增加,尤其是在低收入和中等收入国家。
- 已提出考虑多种风险因素的个性化筛查间期,并具有良好的成本效益比。
- 许多国家全国性筛查规划的资源稀缺。
- 扫描共焦眼科超广角成像、手持移动设备、远程眼科远程分级以及人工智能自动检测和分类糖尿病视网膜病变等新技术,正在改变筛查策略并提高成本效益。
临床怎么用
- 糖尿病视网膜病变筛查对于检出需及时全面眼科检查 and 治疗的可转诊病例至关重要,以避免永久性视力丧失。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although the prevalence of all stages of diabetic retinopathy has been declining since 1980 in populations with improved diabetes control, the crude prevalence of visual impairment and blindness caused by diabetic retinopathy worldwide increased between 1990 and 2015, largely because of the increasing prevalence of type 2 diabetes, particularly in low-income and middle-income countries. Screening for diabetic retinopathy is essential to detect referable cases that need timely full ophthalmic examination and treatment to avoid permanent visual loss. In the past few years, personalised screening intervals that take into account several risk factors have been proposed, with good cost-effectiveness ratios. However, resources for nationwide screening programmes are scarce in many countries. New technologies, such as scanning confocal ophthalmology with ultrawide field imaging and handheld mobile devices, teleophthalmology for remote grading, and artificial intelligence for automated detection and classification of diabetic retinopathy, are changing screening strategies and improving cost-effectiveness. Additionally, emerging evidence suggests that retinal imaging could be useful for identifying individuals at risk of cardiovascular disease or cognitive impairment, which could expand the role of diabetic retinopathy screening beyond the prevention of sight-threatening disease.
引用
- Vujosevic S, Aldington SJ, Silva P, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020. PMID: 32113513. doi:10.1016/S2213-8587(19)30411-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。